Copyright: ©Author(s) 2026.
World J Psychiatry. Jul 19, 2026; 16(7): 117709
Published online Jul 19, 2026. doi: 10.5498/wjp.117709
Published online Jul 19, 2026. doi: 10.5498/wjp.117709
Table 3 Selective serotonin reuptake inhibitors titration schedule (mg/day)
| Medication | Starting dose | Increments | Effective dose | Maximum dose | Titration period | Safety instructions |
| Fluoxetine | 10 | 10-20 | 20 | 60 | Titrate to 20 mg/day after 1 week; consider lower dose for low-weight adolescent | Monitor for suicidal ideation and behavior |
| Contraindicated with MAOIs | ||||||
| Long half-life | ||||||
| Monitor for activation syndrome | ||||||
| Refer to prescribing information for complete safety data | ||||||
| Sertraline | 25 | 12.5-25 | 50 | 200 | Titrate over 2-4 weeks, intervals ≥ 1 week | Monitor for suicidal ideation and behavior |
| Contraindicated with MAOIs | ||||||
| QT prolongation risk; ECG monitoring when indicated | ||||||
| Monitor for manic switch | ||||||
| Monitor for abnormal bleeding | ||||||
| Periodic hepatic and renal function monitoring | ||||||
| Refer to prescribing information for complete safety data | ||||||
| Escitalopram | 10 | 5 | 10 | 20 | Titrate over 2-4 weeks, intervals ≥ 1 week | Monitor for suicidal ideation and behavior |
| Contraindicated with MAOIs | ||||||
| Monitor for manic switch | ||||||
| Monitor for abnormal bleeding | ||||||
| Monitor for serotonin syndrome | ||||||
| Monitor for hyponatremia | ||||||
| Refer to prescribing information for complete safety data | ||||||
| Citalopram | 10 | 10 | 20 | 40 | Titrate over 2-4 weeks, intervals ≥ 1 week | Monitor for suicidal ideation and behavior |
| Contraindicated with MAOIs | ||||||
| Monitor for manic switch | ||||||
| Monitor for serotonin syndrome | ||||||
| Monitor for hyponatremia | ||||||
| Refer to prescribing information for complete safety data | ||||||
| Fluvoxamine | 25 | 25 | 50 | 200 | Titrate by 25 mg every 4-7 days | Monitor for suicidal ideation and behavior |
| Contraindicated with MAOIs | ||||||
| Monitor for manic switch | ||||||
| CYP450 inhibitor; multiple drug interactions | ||||||
| Refer to prescribing information for complete safety data |
- Citation: Wang YF, Yan W, Bai C, Liu XX, Wang Z, Zhong Y, Yuan YG, Guo RJ, Lu L. Clinical guidelines for adolescent depression: An integrated traditional Chinese and Western medicine approach. World J Psychiatry 2026; 16(7): 117709
- URL: https://www.wjgnet.com/2220-3206/full/v16/i7/117709.htm
- DOI: https://dx.doi.org/10.5498/wjp.117709